LIVERPOOL, ENGLAND – Anti–tumor necrosis factor treatment significantly decreased fatigue in patients with rheumatoid arthritis in an analysis of data from the British Society for Rheumatology <link...

Field of Interest: Rheumatology

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness